Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-627-4 | CAS number: 85-73-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The substance phthalylsulfathiazole is not toxic by oral and inhalation route through repeated dose.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- (Q)SAR
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Justification for type of information:
- QSAR prediction: migrated from IUCLID 5.6
- Qualifier:
- according to guideline
- Guideline:
- other: estimated data
- Principles of method if other than guideline:
- Prediction is done using QSAR Toolbox version 2.3.
- GLP compliance:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- not specified
- Route of administration:
- oral: unspecified
- Vehicle:
- unchanged (no vehicle)
- Dose descriptor:
- LOEL
- Effect level:
- 386.755 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: not specified
- Remarks on result:
- other: not specified
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Conclusions:
- Repeated dose toxicity LOEL (Lowest observed effect level) of phthalylsulfathiazole in rat (Sprague-Dawley) by the oral route was estimated at a dose concentration of 386.7549 mg/kg/day.
- Executive summary:
Repeated dose toxicity LOEL (Lowest observed effect level) of phthalylsulfathiazole in rat (Sprague-Dawley) by the oral route was estimated at a dose concentration of 386.7549 mg/kg/day.On the basis of this LOEL value it is concluded that the test substance is not toxic to rat (Sprague-Dawley) by oral route below the above mentioned dose.
Reference
The
prediction was based on dataset comprised from the following
descriptors: "effect LOEL"
Estimation method: Taking average value from the 5 nearest neighbours
Domain logical expression:Result: In Domain
((("a"
and "b" )
and "c" )
and ("d"
and "e" )
)
Domain
logical expression index: "a"
Similarity
boundary:Target:
C(=O)(O)c1c(C(=O)Nc2ccc(S(=O)(=O)NC3=NC=CS3)cc2)cccc1
Threshold=50%,
Dice(Atom pairs)
Domain
logical expression index: "b"
Referential
boundary: The
target chemical should be classified as High (Class III) by Toxic hazard
classification by Cramer (original)
Domain
logical expression index: "c"
Referential
boundary: The
target chemical should be classified as No superfragment by
Superfragments
Domain
logical expression index: "d"
Parametric
boundary:The
target chemical should have a value of log Kow which is >= 2.41
Domain
logical expression index: "e"
Parametric
boundary:The
target chemical should have a value of log Kow which is <= 3.06
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- 386.755 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- K2 data from QSAR model considered relaible by OECD
Repeated dose toxicity: inhalation - systemic effects
Link to relevant study records
- Endpoint:
- sub-chronic toxicity: inhalation
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Justification for type of information:
- QSAR prediction: migrated from IUCLID 5.6
- Qualifier:
- according to guideline
- Guideline:
- other: estimated data
- Principles of method if other than guideline:
- Prediction is done using QSAR Toolbox version 2.3.
- GLP compliance:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- not specified
- Route of administration:
- inhalation
- Type of inhalation exposure:
- not specified
- Vehicle:
- not specified
- Analytical verification of doses or concentrations:
- not specified
- Dose descriptor:
- LOEL
- Effect level:
- 106.227 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: not specified
- Remarks on result:
- other: not specified
- Critical effects observed:
- not specified
- Organ:
- not specified
- Conclusions:
- Repeated dose toxicity LOEL (Lowest observed effect level) of phthalylsulfathiazole to rat (Sprague-Dawley)by the inhalation route was estimated at a dose concentration of 106.2268 mg/kg/day.
- Executive summary:
Repeated dose toxicity LOEL (Lowest observed effect level) of phthalylsulfathiazole to rat (Sprague-Dawley)by the inhalation route was estimated at a dose concentration of 106.2268 mg/kg/day. On the basis of this LOEL value it is concluded that the substance phthalylsulfathiazole is not toxic to rat (Sprague-Dawley) by inhalative route below the above mentioned dose.
Reference
The
prediction was based on dataset comprised from the following
descriptors: "effect LOEL"
Estimation method: Taking average value from the 5 nearest neighbours
Domain logical expression:Result: In Domain
("a"
and ("b"
and "c" )
)
Domain
logical expression index: "a"
Similarity
boundary:Target:
C(=O)(O)c1c(C(=O)Nc2ccc(S(=O)(=O)NC3=NC=CS3)cc2)cccc1
Threshold=50%,
Dice(Atom pairs)
Domain
logical expression index: "b"
Parametric
boundary:The
target chemical should have a value of log Kow which is >= -2.14
Domain
logical expression index: "c"
Parametric
boundary:The
target chemical should have a value of log Kow which is <= 4.85
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- 106.227
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- K2 data from QSAR model considered relaible by OECD
Repeated dose toxicity: dermal - systemic effects
Link to relevant study records
- Endpoint:
- repeated dose toxicity: dermal
- Data waiving:
- other justification
- Justification for data waiving:
- other:
- Critical effects observed:
- not specified
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Repeated dose toxicity :
Repeated dose toxicity : Oral
Repeated dose toxicity LOEL (Lowest observed effect level) of phthalylsulfathiazole in rat (Sprague-Dawley) by the oral route was estimated at a dose concentration of 386.7549 mg/kg/day.On the basis of this LOEL value it is concluded that the test substance is not toxic to rat (Sprague- Dawley)by oral route below the above mentioned dose. The supporting studies showes TDLo - Lowest published toxic dose values for phthalylsulfathiazole also support the key study indicating non toxic behaviour of the substance.
Repeated dose toxicity : Inhalation
Repeated dose toxicity LOEL (Lowest observed effect level) of phthalylsulfathiazole to rat (Sprague-Dawley)by the inhalation route was estimated at a dose concentration of 106.2268 mg/kg/day.On the basis of this LOEL value it is concluded that the substance phthalylsulfathiazole is not toxic to rat (Sprague-Dawley) by inhalative route below the above mentioned dose.
Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
Repeated dose toxicity LOEL (Lowest observed effect level) of phthalylsulfathiazole in rat (Sprague-Dawley) by the oral route was estimated at a dose concentration of 386.7549 mg/kg/day.On the basis of this LOEL value it is concluded that the test substance is not toxic to rat (Sprague-Dawley)by oral route below the above mentioned dose.
Justification for selection of repeated dose toxicity inhalation - systemic effects endpoint:
Repeated dose toxicity LOEL (Lowest observed effect level) of phthalylsulfathiazole to rat (Sprague-Dawley)by the inhalation route was estimated at a dose concentration of 106.2268 mg/kg/day.On the basis of this LOEL value it is concluded that the substance phthalylsulfathiazole is not toxic to rat (Sprague-Dawley) by inhalative route below the above mentioned dose.
Justification for selection of repeated dose toxicity dermal - systemic effects endpoint:
There are studies that indicate the acute dermal toxicity (LD50) of phthalylsulfathiazole on rat to be greater than 2000 mg/kg body weight. Also, this chemical does not show skin sensitization. Thus indicating that the substance will have negligible effect on dermal exposure and thus is not considered for furhter testing.
Justification for classification or non-classification
On the basis of this LOEL value it is concluded that the substance phthalylsulfathiazole is not toxic via inhalation and oral route. Also demal toxicity will be not considerd as acute toxicity is nil.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.